WO2009031730A1 - Method of manufacturing a smoking cessation aiding drink and a smoking cessation aiding drink manufactured by the same - Google Patents
Method of manufacturing a smoking cessation aiding drink and a smoking cessation aiding drink manufactured by the same Download PDFInfo
- Publication number
- WO2009031730A1 WO2009031730A1 PCT/KR2007/006103 KR2007006103W WO2009031730A1 WO 2009031730 A1 WO2009031730 A1 WO 2009031730A1 KR 2007006103 W KR2007006103 W KR 2007006103W WO 2009031730 A1 WO2009031730 A1 WO 2009031730A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nicotine
- weight
- fruit
- smoking cessation
- smoking
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 9
- 230000005586 smoking cessation Effects 0.000 title description 7
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 26
- 239000000126 substance Substances 0.000 claims abstract description 18
- 229940124535 smoking cessation aid Drugs 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000000843 powder Substances 0.000 claims abstract description 13
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 10
- 239000002245 particle Substances 0.000 claims abstract description 9
- 239000012535 impurity Substances 0.000 claims abstract description 5
- 238000010298 pulverizing process Methods 0.000 claims abstract description 5
- 238000002156 mixing Methods 0.000 claims abstract description 4
- 238000005406 washing Methods 0.000 claims abstract description 4
- 235000015203 fruit juice Nutrition 0.000 claims description 9
- 241000220324 Pyrus Species 0.000 claims description 7
- 235000021017 pears Nutrition 0.000 claims description 6
- 235000009434 Actinidia chinensis Nutrition 0.000 claims description 3
- 235000009436 Actinidia deliciosa Nutrition 0.000 claims description 3
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 3
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 3
- 240000003768 Solanum lycopersicum Species 0.000 claims description 3
- 241000271567 Struthioniformes Species 0.000 claims description 3
- 235000021016 apples Nutrition 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 244000144730 Amygdalus persica Species 0.000 claims 1
- 244000141359 Malus pumila Species 0.000 claims 1
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 abstract description 62
- 229960002715 nicotine Drugs 0.000 abstract description 62
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 abstract description 62
- 230000000391 smoking effect Effects 0.000 abstract description 24
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 abstract description 8
- 210000000056 organ Anatomy 0.000 abstract description 5
- 230000009467 reduction Effects 0.000 abstract description 3
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 22
- 241000208125 Nicotiana Species 0.000 description 21
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 16
- 239000000779 smoke Substances 0.000 description 12
- 239000003814 drug Substances 0.000 description 11
- 235000019504 cigarettes Nutrition 0.000 description 10
- 229940079593 drug Drugs 0.000 description 10
- 229960003638 dopamine Drugs 0.000 description 8
- 230000006378 damage Effects 0.000 description 7
- 206010012335 Dependence Diseases 0.000 description 6
- 230000003542 behavioural effect Effects 0.000 description 6
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 6
- 230000034994 death Effects 0.000 description 6
- 210000001009 nucleus accumben Anatomy 0.000 description 6
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 5
- 102000005962 receptors Human genes 0.000 description 5
- 108020003175 receptors Proteins 0.000 description 5
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 206010057852 Nicotine dependence Diseases 0.000 description 4
- 102000019315 Nicotinic acetylcholine receptors Human genes 0.000 description 4
- 108050006807 Nicotinic acetylcholine receptors Proteins 0.000 description 4
- 208000025569 Tobacco Use disease Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 4
- 210000004515 ventral tegmental area Anatomy 0.000 description 4
- 235000019155 vitamin A Nutrition 0.000 description 4
- 239000011719 vitamin A Substances 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 3
- 206010070834 Sensitisation Diseases 0.000 description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229960003920 cocaine Drugs 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000003291 dopaminomimetic effect Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 235000008216 herbs Nutrition 0.000 description 3
- 230000001473 noxious effect Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 230000008313 sensitization Effects 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 229940045997 vitamin a Drugs 0.000 description 3
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 2
- 206010010219 Compulsions Diseases 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 244000286838 Eclipta prostrata Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 244000070406 Malus silvestris Species 0.000 description 2
- 240000004371 Panax ginseng Species 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 240000005809 Prunus persica Species 0.000 description 2
- 241000208292 Solanaceae Species 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 229910002091 carbon monoxide Inorganic materials 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000005056 cell body Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 235000020774 essential nutrients Nutrition 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 231100000636 lethal dose Toxicity 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 229960005181 morphine Drugs 0.000 description 2
- 239000005445 natural material Substances 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 125000000168 pyrrolyl group Chemical group 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 208000011117 substance-related disease Diseases 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 1
- MTXSIJUGVMTTMU-JTQLQIEISA-N (S)-anabasine Chemical compound N1CCCC[C@H]1C1=CC=CN=C1 MTXSIJUGVMTTMU-JTQLQIEISA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- MYKUKUCHPMASKF-VIFPVBQESA-N (S)-nornicotine Chemical compound C1CCN[C@@H]1C1=CC=CN=C1 MYKUKUCHPMASKF-VIFPVBQESA-N 0.000 description 1
- YYJCSIKNHFNEQM-UHFFFAOYSA-N 1-(1-methyl-3,6-dihydro-2h-pyridin-4-yl)ethanone Chemical compound CN1CCC(C(C)=O)=CC1 YYJCSIKNHFNEQM-UHFFFAOYSA-N 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 108010009685 Cholinergic Receptors Proteins 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000195950 Equisetum arvense Species 0.000 description 1
- 239000005768 Equisetum arvense L. Substances 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010023825 Laryngeal cancer Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 241000195948 Lycopodiaceae Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- MYKUKUCHPMASKF-UHFFFAOYSA-N Nornicotine Natural products C1CCNC1C1=CC=CN=C1 MYKUKUCHPMASKF-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 239000008896 Opium Substances 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 244000303286 Stachys officinalis Species 0.000 description 1
- 235000009225 Stachys officinalis Nutrition 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- SHGAZHPCJJPHSC-NWVFGJFESA-N Tretinoin Chemical compound OC(=O)/C=C(\C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NWVFGJFESA-N 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 241001002356 Valeriana edulis Species 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 102000034337 acetylcholine receptors Human genes 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229940025084 amphetamine Drugs 0.000 description 1
- 229930014345 anabasine Natural products 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002331 anti-herbivore Effects 0.000 description 1
- 230000003502 anti-nociceptive effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 238000013528 artificial neural network Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000000376 autoradiography Methods 0.000 description 1
- 239000003637 basic solution Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000007321 biological mechanism Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 210000005064 dopaminergic neuron Anatomy 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 201000004101 esophageal cancer Diseases 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 102000034240 fibrous proteins Human genes 0.000 description 1
- 108091005899 fibrous proteins Proteins 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 1
- 239000002316 fumigant Substances 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 244000237330 gutta percha tree Species 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 206010023841 laryngeal neoplasm Diseases 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 229960001252 methamphetamine Drugs 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000001577 neostriatum Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 239000002581 neurotoxin Substances 0.000 description 1
- 231100000618 neurotoxin Toxicity 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229960001027 opium Drugs 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 235000015206 pear juice Nutrition 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 210000001428 peripheral nervous system Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000033458 reproduction Effects 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000008054 signal transmission Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 235000019505 tobacco product Nutrition 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000005068 transpiration Effects 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 231100000925 very toxic Toxicity 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
- A23L2/04—Extraction of juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
Definitions
- the present invention relates to a drinkable smoking cessation aid and a method of manufacturing the same. More particularly, the present invention relates to a drinkable smoking cessation aid comprising 20-40 weight % fruit juice and 2-5 weight % baking powder, which can remove nicotine from the esophagus, the stomach and the large intestine, thereby alleviating nicotine withdrawal symptoms, and a preparation method thereof Background Art
- Mcotine representative of tobacco toxicity, is a colorless alkaloid which causes vomiting, dizziness and headaches when it is inhaled in the form of smoke. The toxic compound is not destroyed when a tobacco cigarette is smoked. Once absorbed into the lungs, nicotine reaches the brain within 7 seconds.
- nicotine itself is very toxic, with a lethal dose of 1 mg per weight kg for adults.
- R>r example an adult weighing 60 kg may be killed with only 60 mg of nicotine if it is absorbed into the bloodstream all at once.
- low nicotine cigarettes have been suggested, and herbs other than tobacco have been used to make nicotine-free cigarettes.
- these cigarette products do not satisfy smokers. Particularly, in the latter case, the smokers cannot enjoy the tobacco flavor.
- Nicotine is a pale yellow, oily liquid that smells like pyridine, with a melting point of 247 0 C (partial degradation) and a specific gravity of 1.0097. This alkaloid is highly volatile at room temperature, and turns brown as a result of oxidation when exposed to light or air. Nicotine is limitlessly soluble in water at temperatures less than 6O 0 C or higher than 21O 0 C, with weak alkalinity in aqueous solution. Nicotine is synthesized in tobacco roots and is translocated through transpiration streams to leaves, where it accumulates, like inorganic salts. In tobacco leaves, malic acid and citric acid are present.
- Nicotine has been found to constitute approximately 0.5-0.8% of the dry weight of tobacco. Nicotine consists of a pyridine ring and a pyrrole ring, and the biosynthesis mechanism thereof remains unknown, with the suggestion that the pyrrole ring is derived from ornitine.
- tobacco contains nicotine analogues, such as nornicotine and anabasine.
- nicotine is found in the nightshade family of plants (Solanaceae) including tobacco, and in lower quantities in Eclipta prostrata L. (E. alba Hasskari), Equisetum arvense L., two or three species of the Lycopodiaceae family. Nicotine is noxious enough to excite or paralyze the central nervous system or the peripheral nervous system. Also, nicotine contracts the intestinal tract and blood vessels, giving rise to an increase in blood pressure. Therefore, acute or chronic addiction to nicotine may result in various diseases.
- Sulfate salts of nicotine function as antiherbivore chemicals, being potent neurotoxins with particular specificity to insects; therefore nicotine is widely used as an insecticide in the form of a fumigant or a contact agent.
- WHO World Health Organization
- addiction is defined as the repeated use of a psychoactive substance or substances to the extent that the user shows a compulsion to take the preferred substance (or substances) due to psychological dependence, and has great difficulty in voluntarily ceasing or modifying substance use due to physical dependence, being psychological and physical injury.
- Dependence refers to a state in which there is a desire for a substance to solve or avoid strain or psychological discomfort and withdrawal symptoms appear upon the discontinuation of use of the substance.
- smoking is regarded as a habitual behavior which is repetitively and intensively conducted in association with specific situations, such as post-meal, drinking, meeting, etc.
- factors that incite smoking include handling tobacco-related objects, such as lighters, matches, etc., environmental smoke, memory of the feeling of the throat upon smoking, etc. Nicotine withdrawal symptoms, which give unpleasant feelings to an addict, disappear when he or she starts to smoke. Thus, if this situation is repeated, an unpleasant feeling resulting from stress or discontent induces smoking.
- the WHO defines addiction as the repeated use of a psychoactive substance or substances to the extent that the user shows a compulsion to take the desired substance (or substances) due to psychological dependence, and has great difficulty in voluntarily ceasing or altering substance use due to physical dependence, to the point of psychological and physical injury.
- nicotine dependence refers to a state in which a user desires nicotine to solve or avoid strain or emotional discomfort, and shows characteristic withdrawal symptoms upon the cessation of nicotine intake.
- Mcotine functions as a ligand in vivo, targeting nicotinic acetylcholine receptors.
- Mcotinic acetylcholine receptors are made up of five receptor subunits, arranged symmetrically around the central pore. Twelve types of nicotinic receptor subunits, ⁇ 2 through 10 and ⁇ 2 through 4 combine to form pentamers.
- a nicotinic receptor may be a hetero-oligomeric receptor consisting of ⁇ subunits and ⁇ subunits or a homo-oligomeric receptor consisting of ⁇ subunits only.
- ⁇ 4/ ⁇ 2 subunits are known to play an important role in signal transmission.
- the ⁇ 4 subunit, possibly associated with the ⁇ 2 subunit, is reported to be crucial for nicotine-elicited antinociception. Therefore, a first step for selecting a nicotine substitute is to determine whether it can bind to the ⁇ 4/ ⁇ 2 subunits.
- GTS ginseng total saponin
- the present invention provides a method of manufacturing a drinkable smoking cessation aid, comprising: washing sound fruit, rather than bruised or diseased fruit, with clean water to remove impurities and residual chemicals therefrom; pulverizing the sound fruit into particles ranging from 0.3 to 0.7 cm in size; squeezing the fruit particles to produce juice; mixing 20 ⁇ 40 weight % of the juice with 2 - 5 weight % of baking powder and a balance to 100 weight % of water.
- the present invention provides a drinkable smoking cessation aid, comprising 20-40 weight % of fruit juice, 2-5 weight % of baking powder and a balance to 100 weight % of water.
- the drinkable smoking cessation aid of the present invention man- ufactured by washing sound fruit, apart from bruised or diseased fruit, with clean water to remove impurities and residual chemicals therefrom; pulverizing the sound fruit into particles ranging from 0.3 to 0.7 cm in size; squeezing the fruit particles to produce juice; mixing 20 ⁇ 40 weight % of the juice with 2 - 5 weight % of baking powder and a balance of water to realize 100 weight %, can remove or neutralize nicotine from the organs of the body, thereby helping smokers quit smoking with notable reduction in nicotine withdrawal symptoms.
- HG. 1 is a flow chart illustrating the process of manufacturing a drinkable smoking cessation aid in accordance with an embodiment of the present invention.
- Vitamin C is an essential nutrient because of humans lack of ability to synthesize it.
- Vitamin A is an essential human nutrient which is found to be responsible for vision, growth, reproduction, and immunity. It exists not as a single compound, but in several forms. In foods of animal origin, the major form of vitamin A is an alcohol (retinol), but can also exist as an aldehyde (retinal), or as an acid (retinoic acid). Precursors to the vitamin present in foods of plant origin as some of the members of the carotenoid family of compounds. Fruits, as well as green-yellow vegetables, are abundant in vitamin A. It has been found to be useful in the prevention of various cancers including lung cancer, esophageal cancer, stomach cancer, bladder cancer, laryngeal cancer, prostate cancer, etc.
- Flavonoids are most commonly known for their activity against reactive oxygen species, which lead cells to aging and death through oxidation. Flavonoids are contained in a large amount in fruit, particularly in tangerines, grapes and peaches, and are known to be therapeutically useful for various kinds of cancer afflicting women.
- fruits contain other beneficial nutrients.
- As food fruit is provided unchanged or in various processed forms with improvements in the standard of living and the development of dietary culture.
- fruit juice all of the components of fruit, such as various minerals, carbohydrates, lipids, etc., are contained.
- any extract can be used in the present invention.
- juices of pears, kiwis, apples, and tomatoes were clinically found to be useful in the preparation of drinkable smoking cessation aids, which have a long-lasting effect of aiding smoking cessation.
- the present invention provides a drinkable smoking cessation aid, comprising 20 ⁇ 40 weight % fruit juice, 2 - 5 weight % baking powder and a balance of water to achieve 100 weight %.
- the drinkable aid does not have a sufficient effect of aiding smoking cessation.
- An amount of fruit juice more than 40 weight % increases the production cost and makes it inconvenient to drink the aid.
- Baking powder serves to macerate nicotine so that nicotine is easily released from the organs. An amount less than 2 weight % of baking powder is too little to neutralize and eliminate nicotine. When the amount of baking powder exceeds 5 weight %, it may cause diarrhea while eliminating nicotine from the organs.
- fruit juice was prepared from pears. Sound pears, separated from bruised or diseased pears, were washed with clean water to remove impurities and residual chemicals therefrom, followed by pulverizing them into a size of 0.3 ⁇ 0.7cm. Theses pear particles were squeezed to form 100% pure juice. To 100 cc of the pear juice was added 15 cc of baking powder, along with a balance to 300 cc of water.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Disclosed is a drinkable smoking cessation aid and a method of manufacturing the same, comprising washing sound fruit, apart from bruised or diseased fruit, with clean water to remove impurities and residual chemicals therefrom; pulverizing the sound fruits into particles ranging from 0.3 to 0.7 cm in size; squeezing the fruit particles to produce juice; mixing 20 ~ 40 weight % of the juice with 2 - 5 weight % baking powder and a balance of water to achieve 100 weight %. When ingested, the drinkable smoking cessation aid can remove or neutralize nicotine from the organs in the body, thereby helping smokers quit smoking with significant reduction in nicotine withdrawal symptoms.
Description
Description
METHOD OF MANUFACTURING A SMOKING CESSATION AIDING DRINK AND A SMOKING CESSATION AIDING DRINK MANUFACTURED BY THE
SAME Technical Field
[1] The present invention relates to a drinkable smoking cessation aid and a method of manufacturing the same. More particularly, the present invention relates to a drinkable smoking cessation aid comprising 20-40 weight % fruit juice and 2-5 weight % baking powder, which can remove nicotine from the esophagus, the stomach and the large intestine, thereby alleviating nicotine withdrawal symptoms, and a preparation method thereof Background Art
[2] Tobacco had already long been used in the Americas when European settlers arrived and introduced the practice to Europe, where it became hugely popular. Since the introduction of tobacco to the European continent, tobacco use has rapidly propagated all over the world. Once, tobacco was used for psychiatric therapy. In addition, tobacco was used for ceremonies due to its smoke.
[3] However, tobacco is known to be noxious and addictive. Many recent studies revealed the seriously harmful effects of tobacco on the body and on psychiatric health. Smoking is not limited to adults, both men and women, but is now spreading to youth, thus having an evil influence on all of society.
[4] As many as seven thousand different components are contained in the smoke of tobacco. Of them, approximately 30 kinds of materials are fatally noxious to the body, including tar, carbon monoxide, bronchitis inducers, and nicotine. Tar has already been identified as a carcinogen. When diffused into the bloodstream, carbon monoxide acts to deplete oxygen in the blood. In addition to being harmful, nicotine is as addictive or more addictive than drugs, and thus many smokers fail to quit smoking. In the past, nicotine was mistakenly understood to be non-addictive, and thus treated differently from cocaine. As the identity of nicotine was revealed, however, the FDA issued its final regulation restricting the sale and marketing of nicotine-containing cigarettes and smokeless tobacco products in 1996. Also, the WHO has recently declared war on tobacco firms.
[5] Mcotine, representative of tobacco toxicity, is a colorless alkaloid which causes vomiting, dizziness and headaches when it is inhaled in the form of smoke. The toxic compound is not destroyed when a tobacco cigarette is smoked. Once absorbed into the lungs, nicotine reaches the brain within 7 seconds.
[6] As mentioned above, nicotine itself is very toxic, with a lethal dose of 1 mg per weight kg for adults. R>r example, an adult weighing 60 kg may be killed with only 60 mg of nicotine if it is absorbed into the bloodstream all at once. When account is taken of the fact that one cigarette contains nicotine in an amount of 10 ~ 20 mg, 3 to 6 cigarettes would kill an adult if he were to chew them together at the same time. C ompared to potassium cyanide, the lethal dose of which is 150 mg for 60 kg adult, nicotine is 2 to 3 times more poisonous. In order to overcome this problem, low nicotine cigarettes have been suggested, and herbs other than tobacco have been used to make nicotine-free cigarettes. However, these cigarette products do not satisfy smokers. Particularly, in the latter case, the smokers cannot enjoy the tobacco flavor.
[7] Now, it is publicly recognized that while a smoker enjoys a cigarette, the smoke harms those around the smoker in various ways. R>r all that, it is very difficult for smokers to quit smoking. There is no means of protection from secondhand smoke without quitting smoking. Further, the phenomenon in which quitting smoking leads to obesity causes smokers to hesitate to quit smoking.
[8] The chemical formula for nicotine is C10H14N2. Nicotine is a pale yellow, oily liquid that smells like pyridine, with a melting point of 2470C (partial degradation) and a specific gravity of 1.0097. This alkaloid is highly volatile at room temperature, and turns brown as a result of oxidation when exposed to light or air. Nicotine is limitlessly soluble in water at temperatures less than 6O0C or higher than 21O0C, with weak alkalinity in aqueous solution. Nicotine is synthesized in tobacco roots and is translocated through transpiration streams to leaves, where it accumulates, like inorganic salts. In tobacco leaves, malic acid and citric acid are present. Nicotine has been found to constitute approximately 0.5-0.8% of the dry weight of tobacco. Nicotine consists of a pyridine ring and a pyrrole ring, and the biosynthesis mechanism thereof remains unknown, with the suggestion that the pyrrole ring is derived from ornitine.
[9] In aάϊtion to nicotine, tobacco contains nicotine analogues, such as nornicotine and anabasine. Also, nicotine is found in the nightshade family of plants (Solanaceae) including tobacco, and in lower quantities in Eclipta prostrata L. (E. alba Hasskari), Equisetum arvense L., two or three species of the Lycopodiaceae family. Nicotine is
noxious enough to excite or paralyze the central nervous system or the peripheral nervous system. Also, nicotine contracts the intestinal tract and blood vessels, giving rise to an increase in blood pressure. Therefore, acute or chronic addiction to nicotine may result in various diseases. Sulfate salts of nicotine function as antiherbivore chemicals, being potent neurotoxins with particular specificity to insects; therefore nicotine is widely used as an insecticide in the form of a fumigant or a contact agent. [10] As many as 70% of smokers want to or have tried to quit smoking, but most of them fail. According to the WHO (World Health Organization), addiction is defined as the repeated use of a psychoactive substance or substances to the extent that the user shows a compulsion to take the preferred substance (or substances) due to psychological dependence, and has great difficulty in voluntarily ceasing or modifying substance use due to physical dependence, being psychological and physical injury. Dependence refers to a state in which there is a desire for a substance to solve or avoid strain or psychological discomfort and withdrawal symptoms appear upon the discontinuation of use of the substance.
[H]
[12] Once, nicotine was mistakenly understood to cause neither physical dependence nor harmfulness to society, unlike cocaine. However, nicotine is now recognized to incur physical dependence and harm society, because harm to individuals is identified as harm to society.
[13] In the aspect of addictive intake thereof, smoking is regarded as a habitual behavior which is repetitively and intensively conducted in association with specific situations, such as post-meal, drinking, meeting, etc. Examples of factors that incite smoking include handling tobacco-related objects, such as lighters, matches, etc., environmental smoke, memory of the feeling of the throat upon smoking, etc. Nicotine withdrawal symptoms, which give unpleasant feelings to an addict, disappear when he or she starts to smoke. Thus, if this situation is repeated, an unpleasant feeling resulting from stress or discontent induces smoking.
[14] Other factors associated with addiction include personal characteristics and the social environment. Not all persons try habit-forming drugs, and not all of those who try them become dependent on the drugs. Persons with defiant, adventurous, and emotionally disturbed characters are liable to be addictive to drugs. Advertisements for tobacco showing tough men or sexy girls or depicting adult situations may seduce youths to smoke cigarettes. Also, in a social environment, such as family members or friends who smoke, teenagers are apt to smoke.
[15] Mcotine auction refers to a state in which physical and psychological dependence to nicotine develops. The WHO defines addiction as the repeated use of a psychoactive substance or substances to the extent that the user shows a compulsion to take the desired substance (or substances) due to psychological dependence, and has great difficulty in voluntarily ceasing or altering substance use due to physical dependence, to the point of psychological and physical injury. Particularly, nicotine dependence refers to a state in which a user desires nicotine to solve or avoid strain or emotional discomfort, and shows characteristic withdrawal symptoms upon the cessation of nicotine intake.
[16] When absorbed in a small amount, nicotine gives a user temporary tranquility, such as psychological rest and relaxation. In contrast, a large quantity of nicotine causes addiction, creating a habit-forming dependence. Currently, tobacco is regarded as a drug equivalent to opium. Once a person is addicted to tobacco, he or she habitually smokes cigarettes due to nicotine. When absorbed into the body, nicotine increases the blood cholesterol level and causes injuries to vessels, aggravating arteriosclerosis.
[17] According to statistics from the WHO, the smoking population over the world amounts to accounts for the death of approximately one billion and accounts for the death of approximately three million persons per year, which is a death rate of one person every 10 seconds. Further, it is expected that the annual death in association with smoking will exceed ten million or more within the next 30 years in consideration of the current growth of the smoking population. Mcotine, although not a direct cause of death, is one of the main factors that cause loss resulting from smoking. Despite various and strenuous efforts to quit smoking, 80% of smokers who quit resume smoking again within one year. The high recurrence rate of smoking is attributed to the potent addiction of nicotine. In combination with nicotine analogues as the basis of the neurological mechanism responsible for nicotine addiction, nicotinesdegrading substances may be a solution to the problem of quit smoking.
[18] Mcotine functions as a ligand in vivo, targeting nicotinic acetylcholine receptors.
Mcotinic acetylcholine receptors are made up of five receptor subunits, arranged symmetrically around the central pore. Twelve types of nicotinic receptor subunits, α2 through 10 and β2 through 4 combine to form pentamers. R>r example, a nicotinic receptor may be a hetero-oligomeric receptor consisting of α subunits and β subunits or a homo-oligomeric receptor consisting of α subunits only. Of them, α4/β2 subunits are known to play an important role in signal transmission. The α4 subunit, possibly associated with the β2 subunit, is reported to be crucial for nicotine-elicited
antinociception. Therefore, a first step for selecting a nicotine substitute is to determine whether it can bind to the α4/β2 subunits.
[19] The mesolimbic system and the nigrostriatal pathway, both being main dopaminergic pathways where the neurotransmitter dopamine is found, are known to play an important role in the reinforcing property of addictive drugs, such as cocaine, amphetamine, morphine, etc. These addictive drugs stimulate the nucleus accumbens and the striatum to release dopamine (Dichiara and Imperato, 1988). Also, injury to the dopaminergic neural network results in the loss of the reinforcing property of addictive drugs (Gorrigall et al., 1992). Data from many studies show that nicotine has common neurobiological properties with other addictive drugs, the neural activity of which are mediated through dopaminergic pathways.
[20] When absorbed, nicotine causes relatively perpetual molecular, cellular and behavioral changes, such as in nicotine receptor mRNA level and dopamine level, and hyperactivity disorder. There is a suggestion that the mesolimbic system is a main target for nicotine addiction, which is now supported by direct or indirect experimental evidence. Autoradiography studies reveal that nicotine receptors are highly distributed in the cell body of the ventral tegmental area (VTA) and the peripheral area of the nucleus accumbens (Marks et al., 1992; Wada et al., 1989), and thus, nicotine stimulates VTA neurons (Calabresi et al., 1989). Ibllowing in vitro treatment with nicotine, an increase in dopamine was detected at the nucleus accumbens and the VTA (Clarke et al., 1985; Clarke, 1991). In vitro studies show that nicotine stimulates the dopamine release of the nucleus accumbens, like other addictive drugs, and isoarecolone, a nicotine effector, also acts to increase dopamine release from the nucleus accumbens (Mirza et al., 1996). Thus far, nicotine has been known to stimulate nicotinic acetylcholine receptors distributed over the cell bodies of dopaminergic neurons to release the neurotransmitter dopamine, thus causing sensitization (Benwell and Balfour, 1992).
[21] Recently, some natural substances (herbs) have attracted attention as therapeutics for nicotine addiction because of their nicotine-like ingredients and nicotinesdegrading ingredients, and have been clinically observed to effectively relieve nicotine withdrawal symptoms. However, the molecular biological mechanism and behavioral effect of the natural substances have yet to be proven. Twenty kinds of herbs, including lotus leaves, betony, Perilla herba, Eucommia ulmoides, Smilacis chinae Radix, Evodiae fructus, mugwort, and clove, have been suggested as substitutes for tobacco in various documents and patents. It has recently been reported that saponins, known as active in-
gradients in ginseng, can greatly alleviate nicotine-elicited behavioral changes. R>r example, ginseng total saponin (GTS) acts to block the development of metham- phetamine-induced behavioral sensitization resulting from administration (Kim et al., 1995; Tokuyama et al., 1992) as well as cocaine- or morphine-induced behavioral change (Kim et al., 1994; Kim et al., 1994; Bhargava and Ramarao, 1991). Repetitive treatment with nicotine is known to give rise to behavioral sensitization, with a close correlation between an increase in walking activity and in the dopamine level of the nucleus accumbens.
[22] As a matter of fact, however, none of the above-mentioned studies can help smokers quit smoking. Ibr example, there are no basic solutions for extinguishing the desire to smoke after meals and during bowel evacuation. Disclosure of Invention Technical Problem
[23] Leading to the present invention, intensive and thorough research into smoking cessation aids, conducted by the present inventors aiming to overcome the problems encountered in the prior art, resulted in the finding that a formulation of toxicologically safe fruit juice, baking powder and water is useful as a beverage for aiding smoking cessation, with a notable reduction in nicotine withdrawal symptoms.
[24] It is therefore an object of the present invention to provide a drinkable smoking cessation aid which can remove or reduce nicotine levels in the body and is useful to help smokers quit smoking, and a method for manufacturing the same. Technical Solution
[25] In accordance with an aspect thereof, the present invention provides a method of manufacturing a drinkable smoking cessation aid, comprising: washing sound fruit, rather than bruised or diseased fruit, with clean water to remove impurities and residual chemicals therefrom; pulverizing the sound fruit into particles ranging from 0.3 to 0.7 cm in size; squeezing the fruit particles to produce juice; mixing 20 ~ 40 weight % of the juice with 2 - 5 weight % of baking powder and a balance to 100 weight % of water.
[26] In accordance with another aspect thereof, the present invention provides a drinkable smoking cessation aid, comprising 20-40 weight % of fruit juice, 2-5 weight % of baking powder and a balance to 100 weight % of water.
Advantageous Effects
[27] When ingested, the drinkable smoking cessation aid of the present invention, man-
ufactured by washing sound fruit, apart from bruised or diseased fruit, with clean water to remove impurities and residual chemicals therefrom; pulverizing the sound fruit into particles ranging from 0.3 to 0.7 cm in size; squeezing the fruit particles to produce juice; mixing 20 ~ 40 weight % of the juice with 2 - 5 weight % of baking powder and a balance of water to realize 100 weight %, can remove or neutralize nicotine from the organs of the body, thereby helping smokers quit smoking with notable reduction in nicotine withdrawal symptoms.
[28]
Brief Description of the Drawings
[29] HG. 1 is a flow chart illustrating the process of manufacturing a drinkable smoking cessation aid in accordance with an embodiment of the present invention.
[30]
Best Mode for Carrying Out the Invention
[31] It is generally accepted that most kinds of fruit are good for health. With high contents of various vitamins and fibers, fruit can give various beneficial effects, including skin beauty, alleviation of fatigue, anticancer activity, etc., to those who ingest them. Particularly, vitamins A, C and E are reported to prevent cells from acting abnormally, and thus to significantly reduce cancer occurrence.
[32] Vitamin C is an essential nutrient because of humans lack of ability to synthesize it.
Fruits are sources of vitamin C This essential nutrient is involved in the synthesis of collagen, an inextensible fibrous protein that is found in connective tissue - bone, tendons, and skin, muscles, cartilage, etc. Its deficiency leads to various diseases.
[33] Vitamin A is an essential human nutrient which is found to be responsible for vision, growth, reproduction, and immunity. It exists not as a single compound, but in several forms. In foods of animal origin, the major form of vitamin A is an alcohol (retinol), but can also exist as an aldehyde (retinal), or as an acid (retinoic acid). Precursors to the vitamin present in foods of plant origin as some of the members of the carotenoid family of compounds. Fruits, as well as green-yellow vegetables, are abundant in vitamin A. It has been found to be useful in the prevention of various cancers including lung cancer, esophageal cancer, stomach cancer, bladder cancer, laryngeal cancer, prostate cancer, etc.
[34] Flavonoids are most commonly known for their activity against reactive oxygen species, which lead cells to aging and death through oxidation. Flavonoids are contained in a large amount in fruit, particularly in tangerines, grapes and peaches, and
are known to be therapeutically useful for various kinds of cancer afflicting women.
[35] In addition to these nutrients, fruits contain other beneficial nutrients. As food, fruit is provided unchanged or in various processed forms with improvements in the standard of living and the development of dietary culture. In fruit juice, all of the components of fruit, such as various minerals, carbohydrates, lipids, etc., are contained. As long as it is extracted from fruit, such as pears, apples, kiwis, tomatoes, peaches, etc., any extract can be used in the present invention. Particularly, juices of pears, kiwis, apples, and tomatoes were clinically found to be useful in the preparation of drinkable smoking cessation aids, which have a long-lasting effect of aiding smoking cessation.
[36]
Mode for the Invention
[37] A better understanding of the present invention may be obtained through the following example, which is set forth to illustrate, but is not to be construed as the limit of the present invention.
[38] In accordance with an aspect thereof, the present invention provides a drinkable smoking cessation aid, comprising 20 ~ 40 weight % fruit juice, 2 - 5 weight % baking powder and a balance of water to achieve 100 weight %.
[39] When the fruit juice is contained in an amount less than 20 weight %, the drinkable aid does not have a sufficient effect of aiding smoking cessation. An amount of fruit juice more than 40 weight % increases the production cost and makes it inconvenient to drink the aid.
[40] Baking powder serves to macerate nicotine so that nicotine is easily released from the organs. An amount less than 2 weight % of baking powder is too little to neutralize and eliminate nicotine. When the amount of baking powder exceeds 5 weight %, it may cause diarrhea while eliminating nicotine from the organs.
[41] In an example of the present invention, fruit juice was prepared from pears. Sound pears, separated from bruised or diseased pears, were washed with clean water to remove impurities and residual chemicals therefrom, followed by pulverizing them into a size of 0.3~0.7cm. Theses pear particles were squeezed to form 100% pure juice. To 100 cc of the pear juice was added 15 cc of baking powder, along with a balance to 300 cc of water.
[42] When 30 voluntary smokers took 100 cc of the drinkable smoking cessation aid once a day, their desire to smoke as a result of the detachment and removal of nicotine from the organs thereof was observed to decrease. All of the volunteers, including heavy
smokers who had smoked for 25 years or longer, succeeded in quitting smoking.
Claims
Claims
[1] A method of manufacturing a drinkable smoking cessation aid, comprising: washing sound fruit, rather than from bruised or diseased fruit, with clean water to remove impurities and residual chemicals therefrom; pulverizing the sound fruit into particles ranging from 0.3 to 0.7 cm in size; squeezing the fruit particles to produce juice; and mixing 20 ~ 40 weight % of the juice with 2 - 5 weight % of baking powder and a balance to 100 weight % of water. [2] The method according to claim 1, wherein the fruit is selected from a group consisting of tomatoes, pears, kiwis, apples, peaches and combinations thereof [3] A drinkable smoking cessation aid, comprising 20-40 weight % of fruit juice,
2-5 weight % of baking powder and a balance to 100 weight % of water.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2007-0091001 | 2007-09-07 | ||
KR1020070091001A KR20090025851A (en) | 2007-09-07 | 2007-09-07 | A nonsmoking help drink |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009031730A1 true WO2009031730A1 (en) | 2009-03-12 |
Family
ID=40429029
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2007/006103 WO2009031730A1 (en) | 2007-09-07 | 2007-11-29 | Method of manufacturing a smoking cessation aiding drink and a smoking cessation aiding drink manufactured by the same |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR20090025851A (en) |
WO (1) | WO2009031730A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20110051876A (en) * | 2009-11-11 | 2011-05-18 | 남종현 | Composition having a detoxification effect on smoking |
KR101725386B1 (en) * | 2015-05-22 | 2017-04-11 | 권무길 | Functional food composition having an antidote of nicotine and its preparation |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02164816A (en) * | 1988-12-17 | 1990-06-25 | Seikagaku Kenkyusho:Kk | Drink agent capable of eliminating halitosis from interior of body |
JPH11206331A (en) * | 1998-01-22 | 1999-08-03 | ▲高▼島 広雄 | Processing of wheat embryo bud or rice bran |
EP1392133A2 (en) * | 2001-02-21 | 2004-03-03 | Jung, Jong-Moon | Functional agent for decomposing nicotine and method of preparing the same |
KR100446641B1 (en) * | 1999-07-16 | 2004-09-04 | 주식회사 리젠 바이오텍 | A drink decomposing nicotine and a formulation decomposing the same |
JP2005082587A (en) * | 2003-09-05 | 2005-03-31 | Hyun-Sakku Kim | Composition of galenical extract having detoxication action on nicotine and dioxins |
-
2007
- 2007-09-07 KR KR1020070091001A patent/KR20090025851A/en not_active Application Discontinuation
- 2007-11-29 WO PCT/KR2007/006103 patent/WO2009031730A1/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02164816A (en) * | 1988-12-17 | 1990-06-25 | Seikagaku Kenkyusho:Kk | Drink agent capable of eliminating halitosis from interior of body |
JPH11206331A (en) * | 1998-01-22 | 1999-08-03 | ▲高▼島 広雄 | Processing of wheat embryo bud or rice bran |
KR100446641B1 (en) * | 1999-07-16 | 2004-09-04 | 주식회사 리젠 바이오텍 | A drink decomposing nicotine and a formulation decomposing the same |
EP1392133A2 (en) * | 2001-02-21 | 2004-03-03 | Jung, Jong-Moon | Functional agent for decomposing nicotine and method of preparing the same |
JP2005082587A (en) * | 2003-09-05 | 2005-03-31 | Hyun-Sakku Kim | Composition of galenical extract having detoxication action on nicotine and dioxins |
Also Published As
Publication number | Publication date |
---|---|
KR20090025851A (en) | 2009-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6845777B2 (en) | Composition to reduce or quit smoking addiction | |
KR100739872B1 (en) | Green tea-based substitute for cigarette and method for manufacturing the same | |
Schultes et al. | Hallucinogenic plants | |
KR100370340B1 (en) | Tobacco Substitute Composition | |
WO2005018348A2 (en) | Chewing tobacco substitute with nicotine | |
KR101325122B1 (en) | Composition for aid to stop smoking having effect of nicotine elimination and its manufacturing method | |
CN114652777A (en) | Electronic atomized liquid for relieving pulmonary inflammation and preparation method thereof | |
Stewart | Wicked Plants: The Weed That Killed Lincoln's Mother and Other Botanical Atrocities | |
CN104799427B (en) | Cyclocarya paliurus cigarettes for smoking cessation | |
CN101731747A (en) | Cigarette medicament capable of lowering tar, reducing harm and preventing diseases | |
WO2009031730A1 (en) | Method of manufacturing a smoking cessation aiding drink and a smoking cessation aiding drink manufactured by the same | |
KR19990000236A (en) | Smoking cessation combined use and preparation method thereof | |
KR100470957B1 (en) | The preparation method of tabacco | |
CN107950740A (en) | A kind of tobacco chewing gum rich in selenium | |
CN115721685A (en) | Medicinal composition and application of pilea asteroides | |
US9198943B2 (en) | Silene capensis for inhibiting cravings | |
JPH01202280A (en) | Smoking tobacco and additive diluting article consisting of lonicera plant | |
KR100851254B1 (en) | Mulberry Leaves-Based Cigarette and Method for Manufacturing the same | |
Small | Narcotic plants as sources of medicinals, nutraceuticals, and functional foods | |
JP3691021B2 (en) | Cigarette filters and cigarettes | |
KR101724825B1 (en) | Helpful agent contaiend chicory and aconitie tuber for prohibit smoking | |
KR200324132Y1 (en) | Green-tea tobacco's substitution | |
CN112806561A (en) | Formula of chewing type cigarette substitute food | |
Macfadden | The Truth about Tobacco-How to break the habit | |
Steinmetz | Tobacco: Its History, Cultivation, Manufacture, and Adulterations: Its Use Considered with Reference to Its Influence on the Human Constitution |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07834388 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07834388 Country of ref document: EP Kind code of ref document: A1 |